|
Description:
|
|
A second man has effectively been cured of HIV, but scientists are reluctant to call it a cure.
That's because the method is expensive, painful, and in some cases deadly.
But the so-called London Patient might hold clues about the best way to cure the virus in the long term.
The answers seem to lie in a HIV-resistant gene that emerged during the 16th century plague.
So how much do humans actually need disease in order to keep evolving?
Is it possible that we've wandered into a genetic cul-de-sac, and stalled the evolutionary process?
Featured:
Professor Sharon Lewin, Immunologist, University of Melbourne
Associate Professor Stephen Corbett, School of Public Health, University of Sydney |